Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists. 2016

Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
Almirall R&D Centre, Laureano Miró, 408-410, 08980, Sant Feliu de Llobregat, Barcelona, Spain.

Monocyclic and bicyclic ring systems were investigated as the "core" section of a series of diphenylsulphone-containing acetic acid CRTh2 receptor antagonists. A range of potencies were observed and single-digit nanomolar potencies were obtained in both the monocyclic and bicyclic cores. Residence times for the monocyclic compounds were very short. Some of the bicyclic cores displayed better residence times. A methyl group in the northern part of the core, between the head and tail was a necessary requirement for the beginnings of long residence times. Variations of the tail substitution maximised potencies and residence times.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013450 Sulfones Sulfone
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
November 2014, Bioorganic & medicinal chemistry letters,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
December 2013, Bioorganic & medicinal chemistry,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
May 2012, Bioorganic & medicinal chemistry letters,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
October 2016, Journal of medicinal chemistry,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
May 2018, Biochemical pharmacology,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
March 2010, Bioorganic & medicinal chemistry letters,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
January 1990, NIDA research monograph,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
January 1973, Advances in biochemical psychopharmacology,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
June 1987, Calcified tissue international,
Maria Antonia Buil, and Marta Calbet, and Marcos Castillo, and Jordi Castro, and Cristina Esteve, and Manel Ferrer, and Pilar Forns, and Jacob González, and Sara López, and Richard S Roberts, and Sara Sevilla, and Bernat Vidal, and Laura Vidal, and Pere Vilaseca
August 1987, Agents and actions,
Copied contents to your clipboard!